Use a Rapid-Acting Insulin Analog, Not Regular Insulin
For your patient on Lantus with good basal control who experiences occasional post-prandial spikes after eating sweets, I strongly recommend using a rapid-acting insulin analog (lispro, aspart, or glulisine) rather than regular insulin for correction doses. Regular insulin is the wrong choice here because its slower onset (15 minutes vs. 5 minutes) and longer duration (6-8 hours vs. 3-4 hours) make it poorly suited for correcting discrete post-meal glucose excursions 1.
Why Rapid-Acting Analogs Are Superior
Rapid-acting insulin analogs control post-prandial blood glucose more effectively than regular insulin 1. The pharmacokinetic profile matters significantly:
- Rapid-acting analogs (lispro/Humalog, aspart/NovoLog, glulisine): 5-minute onset, peak at 1-2 hours, duration 3-4 hours 1
- Regular insulin: 15-minute onset, peak at 3-4 hours, duration 6-8 hours 1
The extended duration of regular insulin creates a critical problem: it increases hypoglycemia risk hours after the correction dose when the patient isn't eating, particularly problematic for someone with otherwise stable basal control 1. The rapid-acting analogs match the post-prandial glucose spike more physiologically and clear before the next meal.
Specific Correction Dosing Strategy
For correction (supplemental) dosing in a patient eating meals, use this approach 2:
Start with the "usual" sensitivity column (assuming no special circumstances like advanced age >70, renal impairment, or corticosteroid use):
- Blood glucose 141-180 mg/dL: 4 units
- 181-220 mg/dL: 6 units
- 221-260 mg/dL: 8 units
- 261-300 mg/dL: 10 units
Administer the rapid-acting insulin before meals or at bedtime when hyperglycemia is detected 2. If he's eating sweets with a meal, give it before that meal. If he checks glucose after eating and finds it elevated, give the correction dose immediately.
Important Caveats
Do not use sliding-scale insulin alone without basal insulin—but that's not your situation since he's already on Lantus 2, 3. You're appropriately adding correction doses to existing basal coverage.
Monitor for a pattern: If he consistently requires correction doses, this signals the need to transition from pure correction dosing to scheduled prandial insulin 4. Specifically, if post-prandial glucose repeatedly exceeds 180 mg/dL despite adequate fasting control, add a single scheduled dose of rapid-acting insulin before the meal with the largest excursion (often dinner) 4.
The rapid onset of rapid-acting analogs means less time to recognize hypoglycemia symptoms 1, so ensure your patient understands hypoglycemia recognition and always carries a fast-acting carbohydrate source.
Practical Implementation
Choose any rapid-acting analog based on availability and cost—lispro, aspart, and glulisine are clinically equivalent 1. Pens may improve adherence compared to vials/syringes 1.
Teach the patient to self-administer correction doses based on pre-meal or bedtime glucose readings using the scale above, adjusting the sensitivity column if hypoglycemia occurs (move to lower doses) or if consistently inadequate correction occurs (move to higher doses) 2.
The FDA label for Lantus explicitly states that in type 1 diabetes, short-acting insulin must be used with basal insulin 5, and while your patient likely has type 2 diabetes, the same principle applies when post-prandial control is inadequate with basal insulin alone.